An extension to a phase II study to determine the safety and anti-leukemic effects of STI571 in patients with Philadelphia chromosome-positive leukemia including acute lymphoblastic leukaemia, acute m...

Mise à jour : Il y a 5 ans
Référence : EUCTR2004-001396-19

An extension to a phase II study to determine the safety and anti-leukemic effects of STI571 in patients with Philadelphia chromosome-positive leukemia including acute lymphoblastic leukaemia, acute myeloid leukaemia, and accelerated phase chronic myeloid leukemia

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

•To enable patients to have access to study drug and continue study treatment •To decrease data collection to include overall survival and serious adverse events


Critère d'inclusion

  • Philadelphia chromosome-opositive chronic myeloid leukamia in myeloid blast crisis

Liens